Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AnPac Bio-Medical Science...

    NASDAQ: ANPC · Real-Time Price · USD
    4.30
    -0.14 (-3.15%)
    At close: May 19, 2023, 9:59 PM

    AnPac Bio-Medical Science Statistics

    Share Statistics

    AnPac Bio-Medical Science has 6.27M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 6.27M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 6.04M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,588

    FTD / Avg. Volume

    n/a
    		 7.2%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.6 and the forward PE ratio is null. AnPac Bio-Medical Science's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.6

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.12

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -4.51

    P/FCF Ratio

    n/a
    		 -1.09

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    AnPac Bio-Medical Science has an Enterprise Value (EV) of 72.16M.

    EV / Sales

    n/a
    		 5.99

    EV / EBITDA

    n/a
    		 -0.92

    EV / EBIT

    n/a
    		 -1.31

    EV / FCF

    n/a
    		 -1.27

    Financial Position

    The company has a current ratio of 0.32, with a Debt / Equity ratio of -0.9.

    Current Ratio

    n/a
    		 0.32

    Quick Ratio

    n/a
    		 0.32

    Debt / Equity

    n/a
    		 -0.9

    Debt / EBITDA

    n/a
    		 -0.16

    Debt / FCF

    n/a
    		 -0.22

    Interest Coverage

    n/a
    		 -225.57

    Financial Efficiency

    Return on Equity is 757.52% and Return on Invested Capital is 6053.08%.

    Return on Equity

    n/a
    		 757.52%

    Return on Assets

    n/a
    		 -255.99%

    Return on Invested Capital

    n/a
    		 6053.08%

    Revenue Per Employee

    n/a
    		 $135,325.84

    Profits Per Employee

    n/a
    		 $-1,164,022.47

    Employee Count

    n/a
    		 89

    Asset Turnover

    n/a
    		 0.3

    Inventory Turnover

    n/a
    		 17.66

    Taxes

    Income Tax

    n/a
    		 -2.13M

    Effective Tax Rate

    n/a
    		 2.01%

    Stock Price Statistics

    The stock price has increased by -1.6% in the last 52 weeks. The beta is 1.56, so AnPac Bio-Medical Science's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.56

    52-Week Price Change

    n/a
    		 -1.6%

    50-Day Moving Average

    n/a
    		 5.57

    200-Day Moving Average

    n/a
    		 5.37

    Relative Strength Index (RSI)

    n/a
    		 37.53

    Average Volume (20 Days)

    n/a
    		 22,069

    Income Statement

    In the last 12 months, AnPac Bio-Medical Science had revenue of 12.04M and earned -103.6M in profits. Earnings per share was -54.18.

    Revenue

    n/a
    		 12.04M

    Gross Profit

    n/a
    		 8.34M

    Operating Income

    n/a
    		 -84.14M

    Net Income

    n/a
    		 -103.6M

    EBITDA

    n/a
    		 -78.4M

    EBIT

    n/a
    		 -105.36M

    Earnings Per Share (EPS)

    n/a
    		 -54.18
    Full Income Statement

    Balance Sheet

    The company has 1.87M in cash and 12.31M in debt, giving a net cash position of -10.44M.

    Cash & Cash Equivalents

    n/a
    		 1.87M

    Total Debt

    n/a
    		 12.31M

    Net Cash

    n/a
    		 -10.44M

    Retained Earnings

    n/a
    		 -577.54M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -55.06M and capital expenditures -1.59M, giving a free cash flow of -56.65M.

    Operating Cash Flow

    n/a
    		 -55.06M

    Capital Expenditures

    n/a
    		 -1.59M

    Free Cash Flow

    n/a
    		 -56.65M

    FCF Per Share

    n/a
    		 -29.63
    Full Cash Flow Statement

    Margins

    Gross margin is 69.21%, with operating and profit margins of -698.59% and -860.16%.

    Gross Margin

    n/a
    		 69.21%

    Operating Margin

    n/a
    		 -698.59%

    Pretax Margin

    n/a
    		 -877.85%

    Profit Margin

    n/a
    		 -860.16%

    EBITDA Margin

    n/a
    		 -650.95%

    EBIT Margin

    n/a
    		 -698.59%

    FCF Margin

    n/a
    		 -470.38%

    Dividends & Yields

    ANPC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -167.85%

    FCF Yield

    n/a
    		 -91.79%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ANPC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 4, 2022. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Nov 4, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist